Board of Directors

              LIST OF DIRECTORS AS ON 25-06-2010

 

 

NAME

 

 

DESIGNATION

 

SHRI V.C.NANNAPANENI

S/O LATE  N.LOKADITYUDU

 

 

CHAIRMAN & MANAGING DIRECTOR

 

SHRI C.P.RAVINDRANATH

S/O N.R.MENON

 

 

DIRECTOR –  EXIM BANK NOMINEE

 

SHRI G.S.MURTHY

S/O SHRI G.TATAIAH

 

 

DIRECTOR

 

DR.B.S.BAJAJ

S/O DR.GOBINLAL BAJAJ

 

 

DIRECTOR

 

DR.JASTI  SAMBASIVA RAO

S/O JASTI VENKATESWARLU

 

 

DIRECTOR

 

SHRI. RAJEEV NANNAPANENI

S/o. V.C. NANNAPANENI

 

 

DIRECTOR & CHIEF OPERATING OFFICER

 

Dr. P. BHASKARA NARAYANA

S/o.  LATE P. SATYANARAYANA RAO

 

 

DIRECTOR & CHIEF FINANCIAL OFFICER

 

DR.AKS BHUJANGA RAO

S/O A.RAMAMURTHY

 

 

PRESIDENT (R & D AND TECHNICAL)

 

 
NATCO confirms filing of ANDA for Generic Revlimid 31/08/2010
NATCO denies speculative news 23/08/2010
NATCO reports increased earnings and profits 31/07/2010
NATCO launches Anastrazole in the USA 29/06/2010
NATCO records higher sales, profits 25/06/2010
NATCO launches BENDIT 07/04/2010
NATCO declares an interim dividend of Rs. 2 per share 27/01/2010
Press Release 09/01/2010
NATCO records increase in revenues, profits 29/10/2009
Natco’s note on anti-cancer drug Albupax 19/10/2009
NATCO Pharma launches Swine Flu medicine 18/09/2009
NATCO’s partner – Mylan’s – ANDA accepted for review of Glatiramer Acetate 14/09/2009
News | Careers | Privacy Policy
NATCO House, Road No: 2, Banjara Hills, Hyderabad - 500 033
Powered by www.sholay.in